Table 1.
Preferential practices (>70%) |
Total |
Belgium |
The Netherlands |
Switzerland |
France |
---|---|---|---|---|---|
N = 68 |
N = 10 | N = 7 | N = 14 | N = 37 | |
CI 95% | |||||
First-intention rehydration method |
|
|
|
|
|
ORS oral route |
61 (90%) |
10 (100%) |
5 (71%) |
12 (86%) |
34 (92%) |
CI [80–96] | |||||
ORS pure |
62 (91%) |
10 (100%) |
6 (86%) |
13 (93%) |
33 (89%) |
CI [82–97] | |||||
Rehydration route in case of oral rehydration failure |
|
|
|
|
|
Intra-venous route |
35 (51%) |
0 (0%) |
0 (0%) |
0 (0%) |
35 (95%) |
CI [39–64] | |||||
Nasogastric route (with ORS) |
28 (41%) |
8 (80%) |
7 (100%) |
12 (86%) |
1 (3%) |
CI [29–54] | |||||
Medication in case of oral rehydration failure |
|
|
|
|
|
Ondansetron |
6 (9%) |
0 (0%) |
1 (14%) |
5 (36%) |
0 (0%) |
CI [3–18] | |||||
Racecadotril |
19 (28%) |
0 (0%) |
0 (0%) |
0 (0%) |
19 (51%) |
CI [18–40] | |||||
Laboratory tests in case of oral rehydration failure |
|
|
|
|
|
Electrolytes |
49 (72%) |
8 (80%) |
3 (43%) |
4 (29%) |
34 (92%) |
CI [60–82] | |||||
Blood count |
28 (41%) |
6 (60%) |
2 (29%) |
1 (7%) |
19 (51%) |
CI [29–54] | |||||
C-reactive protein |
25 (37%) |
6 (60%) |
2 (29%) |
1 (7%) |
16 (43%) |
CI [25–49] | |||||
Stool virology |
20 (29%) |
5 (50%) |
2 (29%) |
1 (7%) |
12 (32%) |
CI [19–42] | |||||
Stool culture | 11 (16%) |
2 (20%) | 3 (43%) | 0 (0%) | 6 (16%) |
CI [8–27] |